175 related articles for article (PubMed ID: 31533098)
1. Ivabradine for the Treatment of Acute Mitral-Regurgitation-Related Decompensated Heart Failure.
Lee WC; Fang HY
Cardiology; 2019; 144(3-4):97-100. PubMed ID: 31533098
[TBL] [Abstract][Full Text] [Related]
2. PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial.
Mentz RJ; DeVore AD; Tasissa G; Heitner JF; Piña IL; Lala A; Cole RT; Lanfear DD; Patel CB; Ginwalla M; Old W; Salacata AS; Bigelow R; Fonarow GC; Hernandez AF
Am Heart J; 2020 May; 223():98-105. PubMed ID: 32217365
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol.
Lee WC; Lin YW; Shih JY; Chen ZC; Wu NC; Chang WT
ESC Heart Fail; 2024 Feb; 11(1):251-260. PubMed ID: 37963437
[TBL] [Abstract][Full Text] [Related]
4. Initiation of ivabradine in cardiogenic shock.
Chiu MH; Howlett JG; Sharma NC
ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
[TBL] [Abstract][Full Text] [Related]
5. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
Imamura T; Hori M; Narang N; Besser S; Kinugawa K
Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment.
Geis N; Raake P; Lewening M; Mereles D; Chorianopoulos E; Frankenstein L; Katus HA; Bekeredjian R; Pleger ST
Acta Cardiol; 2018 Aug; 73(4):378-386. PubMed ID: 29161956
[TBL] [Abstract][Full Text] [Related]
9. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
Imamura T; Onoda H; Uchida K; Kinugawa K
Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis.
Ghadimi N; Kaveh S; Shabaninejad H; Lijassi A; Mehr AZ; Hosseinifard H
Int J Clin Pharm; 2019 Feb; 41(1):22-29. PubMed ID: 30659493
[TBL] [Abstract][Full Text] [Related]
12. Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine.
Elder DH; Mohan M; Cochrane L; Charles H; Lang CC
Cardiovasc Ther; 2015 Jun; 33(3):104-8. PubMed ID: 25809454
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of ivabradine in chronic heart failure (review)].
Isakadze A; Makharadze T; Gvishiani M
Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
[TBL] [Abstract][Full Text] [Related]
16. [Chronic Heart Failure With Preserved Ejection Fraction: Effective Treatment Possible?].
Kanorskiy SG; Borisenko YV
Kardiologiia; 2018 Jun; 58(6):85-89. PubMed ID: 30362441
[TBL] [Abstract][Full Text] [Related]
17. Novel drugs for heart rate control in heart failure.
Bielecka-Dabrowa A; von Haehling S; Rysz J; Banach M
Heart Fail Rev; 2018 Jul; 23(4):517-525. PubMed ID: 29594814
[TBL] [Abstract][Full Text] [Related]
18. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.
Chow SL; Page RL; Depre C
Expert Rev Cardiovasc Ther; 2018 Jul; 16(7):515-526. PubMed ID: 29902387
[TBL] [Abstract][Full Text] [Related]
19. Clinical Experience with Ivabradine in Acute Heart Failure.
Pascual Izco M; Alonso Salinas GL; Sanmartín Fernández M; Del Castillo Carnevalli H; Jiménez Mena M; Camino López A; Zamorano Gómez JL
Cardiology; 2016; 134(3):372-4. PubMed ID: 27100325
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implications of Ivabradine in the Contemporary Era.
Imamura T
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
